Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer [Phase 2]
Phase 2 trial evaluating combination chemotherapy plus peripheral stem cell transplantation for relapsed germ cell cancer; results have been…
-
CLINICAL_TRIALS trial_result · 2017-01-02Clinical Trial Update: How Our Immune System Can Help Fight Cancer
The update describes how immune-based strategies are being explored to help treat cancer. It notes that the associated clinical trial (NCT01…
-
CLINICAL_TRIALS research · 2016-12-30Clinical Trial Update: Fluid Balance During Surgery for Ovarian Cancer
This clinical trial update focuses on fluid balance management during ovarian cancer surgery; no results or current status details are discl…
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer [Phase 2]
Phase 2 trial of Hu3S193 as consolidation therapy for women with ovarian, fallopian tube, or primary peritoneal cancer; the study is termina…
-
FDA approval · 2016-12-19FDA Approved: RUBRACA — Original Application (pharmaand GmbH)
FDA approved the original application for Rubraca (rucaparib) from pharmaand GmbH.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-12-19Clinical Trial Update: S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]
A phase 2 trial evaluated docetaxel with or without vandetanib in patients with persistent or recurrent ovarian epithelial cancer, fallopian…
-
CLINICAL_TRIALS trial_result · 2016-12-19Clinical Trial Update: First-line Intraperitoneal Cisplatin and Etoposide Chemotherapy for Ovarian Cancer [Phase 2]
A Phase 2 study evaluating first-line intraperitoneal cisplatin and etoposide for bulky stage IIIC/IV epithelial ovarian cancer and related …
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer [Phase 3]
This update reports the completion of the TRINOVA-1 Phase 3 trial evaluating AMG 386 in combination with weekly paclitaxel for fallopian tub…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors [Phase 2]
Phase 2 trial update on belinostat for advanced ovarian epithelial cancer, primary peritoneal cancer, fallopian tube cancer, and ovarian low…
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: E7080 in Combination With Carboplatin + Gemcitabine Versus Carboplatin + Gemcitabine Alone as Second Line Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer by CA125 [Phase 1, Phase 2]
Clinical trial update for E7080 (lenvatinib) in combination with carboplatin and gemcitabine versus carboplatin and gemcitabine alone as sec…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer. [Phase 1]
Phase I study of alemtuzumab in relapsed ovarian cancer and primary peritoneal cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Laparoscopy for Primary Cytoreductive Surgery in Advanced Ovarian Cancer
This document reports the completion of a clinical trial evaluating laparoscopy for primary cytoreductive surgery in advanced ovarian cancer…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer [Phase 2]
Phase 2 trial of regorafenib in recurrent ovarian, primary peritoneal, and fallopian tube cancer was terminated with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Study of Lenalidomide With Topotecan In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma [Phase 1, Phase 2]
A phase 1/2 trial evaluating the combination of lenalidomide with topotecan in advanced ovarian cancer and primary peritoneal cancer has com…
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma [Phase 2]
Phase 2 trial evaluating DCVAC/OvCa plus standard of care in relapsed platinum-resistant ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-11-25Clinical Trial Update: Taxol Carboplatin and Erythropoetin [Phase 2]
Phase 2 trial evaluating paclitaxel (Taxol) with carboplatin and erythropoietin for ovarian cancer; results from the completed study have be…
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE) [Phase 3]
Phase 3 trial of pertuzumab in platinum-resistant, HER3 mRNA–positive epithelial ovarian cancer (PENELOPE) has completed and posted results.
-
CLINICAL_TRIALS research · 2016-11-22Clinical Trial Update: Phase I Trial: 68Ga-NODAGA-E(c[RGDyK])2 Positron Emission Tomography for Imaging Angiogenesis in Primary and Metastatic Tumor Lesions in Humans [Phase 1]
Phase I imaging trial evaluating 68Ga-NODAGA-E(cRGDyK)2 PET for assessing angiogenesis in primary and metastatic tumors; trial status is unk…
-
FDA approval · 2016-11-17FDA Approved: GEMCITABINE — Supplemental Application (Hospira, Inc.)
FDA approved Hospira, Inc.'s supplemental application for gemcitabine under ANDA 079183. This represents approval of a supplemental submissi…
-
CLINICAL_TRIALS trial_result · 2016-11-16Clinical Trial Update: Bevacizumab and Carboplatin for Patients With Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating bevacizumab in combination with carboplatin for ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-16Clinical Trial Update: Veliparib Monotherapy for Relapsed Ovarian Cancer With BRCA Mutation [Phase 1, Phase 2]
This clinical trial update reports the completion of Phase 1/Phase 2 studies of veliparib as monotherapy in relapsed BRCA-mutated ovarian ca…
-
CLINICAL_TRIALS research · 2016-11-15Clinical Trial Update: BRCA 1/2 Mutation in Korean Patients With Epithelial Ovarian Cancer
A completed clinical trial assessing how common BRCA1/2 mutations are among Korean patients with ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2016-11-11Clinical Trial Update: A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer [Phase 1]
A completed Phase 1 study evaluating liposomal doxorubicin (DOXIL/CAELYX) in patients with advanced or refractory solid malignancies, includ…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Efficacy of Pelvic Autonomic Nerve Monitoring System (PAMS I) in Female Patients With Pelvic Tumors [NA]
This document provides an update on the efficacy of the Pelvic Autonomic Nerve Monitoring System (PAMS I) in female patients with pelvic tum…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Safety and Pharmacokinetics of DMUC5754A Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer [Phase 1]
Phase 1 study evaluating the safety and pharmacokinetics of DMUC5754A administered intravenously in patients with platinum-resistant ovarian…